Concepedia

Janet Woodcock

JW

Statistics

Publications

83

Citations

11.6K

H-Index

42

Active since

1982

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Center for Biologics Evaluation and Research

Massachusetts Institute of Technology

Janet Woodcock is an author at Center for Drug Evaluation and Research specializing in pharmacy, pharmacology, and drug approval processes.

ORCID

Publications per year

1982–2023

83

Publications

83

Real-World Evidence — What Is It and What Can It Tell Us?

Rachel E. Sherman, Steven A. Anderson, Gerald J. Dal Pan et al. · New England Journal of Medicine · 2016 · 2.1K citations

, , +17

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock, Lisa M. LaVange · New England Journal of Medicine · 2017 · 1K citations · Full text

, , +9

Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production

Sau L. Lee, Thomas O’Connor, Xiaochuan Yang et al. · Journal of Pharmaceutical Innovation · 2015 · 853 citations · Full text

, , +14

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Marco Guerrini, Daniela Beccati, Zachary Shriver et al. · Nature Biotechnology · 2008 · 617 citations

, , +7

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly et al. · New England Journal of Medicine · 2008 · 616 citations · Full text

, , +12

1–5 of 83